Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 969.25B | 1.01T | 888.47B | 756.86B | 674.43B | 717.84B |
Gross Profit | 969.25B | 971.83B | 1.02T | 707.71B | 674.43B | 717.84B |
EBITDA | 18.78B | 21.24B | 11.36B | 14.71B | 16.09B | 17.25B |
Net Income | 18.11B | 18.11B | 15.74B | 13.68B | 13.27B | 13.61B |
Balance Sheet | ||||||
Total Assets | 3.49T | 3.49T | 3.03T | 2.48T | 2.31T | 1.80T |
Cash, Cash Equivalents and Short-Term Investments | 76.14B | 76.14B | 29.27B | 11.69B | 32.26B | 34.75B |
Total Debt | 29.50B | 29.50B | 9.50B | 9.50B | 6.00B | 6.00B |
Total Liabilities | 3.33T | 3.33T | 2.88T | 2.35T | 2.15T | 1.71T |
Stockholders Equity | 161.55B | 161.55B | 146.66B | 129.93B | 156.13B | 86.40B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 152.96B | 105.85B | 67.96B | 58.86B | 96.42B |
Operating Cash Flow | 0.00 | 155.97B | 107.21B | 68.83B | 59.43B | 97.03B |
Investing Cash Flow | 0.00 | -136.38B | -136.17B | -100.87B | -8.07B | -89.46B |
Financing Cash Flow | 0.00 | 16.07B | -4.03B | 19.85B | -2.38B | 6.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | ₹1.66T | 88.74 | ― | 0.27% | -5.42% | 14.77% | |
66 Neutral | 934.42B | 34.77 | 16.74% | 0.66% | 15.68% | 26.12% | |
65 Neutral | 546.83B | 199.30 | 6.20% | ― | -3.50% | -28.98% | |
56 Neutral | 862.76B | 68.27 | 9.93% | 0.14% | -23.85% | 44.83% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
HDFC Life Insurance Company Limited has announced a series of investor and analyst meetings scheduled for September 2025. These meetings, taking place both in-person and virtually, aim to engage with stakeholders and provide insights into the company’s operations and strategies. Such interactions are crucial for maintaining transparency and fostering investor confidence, potentially impacting the company’s market perception and stakeholder relations.